Semba Charles Pauling 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Semba Charles Pauling
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-01+32,162→ 32,162 totalExercise: $4.11Exp: 2035-05-31→ Common Shares (32,162 underlying)
Holdings
- 44,608
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 3,967 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan.
- [F2]Vests in four nearly equal quarterly installments over one year.